Mahdi Behzad

580 total citations
31 papers, 448 citations indexed

About

Mahdi Behzad is a scholar working on Immunology, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mahdi Behzad has authored 31 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 6 papers in Pathology and Forensic Medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mahdi Behzad's work include Immune Cell Function and Interaction (8 papers), Diabetes and associated disorders (6 papers) and Psoriasis: Treatment and Pathogenesis (6 papers). Mahdi Behzad is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Diabetes and associated disorders (6 papers) and Psoriasis: Treatment and Pathogenesis (6 papers). Mahdi Behzad collaborates with scholars based in Iran, Türkiye and Germany. Mahdi Behzad's co-authors include Alireza Zamani, Vida Sheikh, Iraj Salehi, Shiva Borzouei, Piraye Oflazer, Feza Deymeer, Fikret Aysal, Güher Saruhan‐Direskeneli, Reza Jafari and Nima Rezaei and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Physiology and Journal of Neuroimmunology.

In The Last Decade

Mahdi Behzad

30 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mahdi Behzad Iran 14 143 113 78 78 60 31 448
Areez Shafqat Saudi Arabia 14 123 0.9× 51 0.5× 34 0.4× 26 0.3× 58 1.0× 45 454
Sibel Oğuzkan Balcı Türkiye 13 59 0.4× 73 0.6× 40 0.5× 23 0.3× 17 0.3× 48 404
Carmela Romano Italy 10 53 0.4× 82 0.7× 101 1.3× 12 0.2× 54 0.9× 16 366
Yongjie Zhao China 9 84 0.6× 40 0.4× 25 0.3× 20 0.3× 25 0.4× 27 504
Valērija Groma Latvia 12 48 0.3× 24 0.2× 30 0.4× 36 0.5× 46 0.8× 53 385
Citlaltepetl Salinas‐Lara Mexico 12 49 0.3× 41 0.4× 12 0.2× 80 1.0× 41 0.7× 49 384
Anne‐Hilde Muris Netherlands 14 262 1.8× 36 0.3× 460 5.9× 53 0.7× 17 0.3× 22 674
K. Huber Austria 10 46 0.3× 33 0.3× 90 1.2× 24 0.3× 19 0.3× 22 434

Countries citing papers authored by Mahdi Behzad

Since Specialization
Citations

This map shows the geographic impact of Mahdi Behzad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahdi Behzad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahdi Behzad more than expected).

Fields of papers citing papers by Mahdi Behzad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahdi Behzad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahdi Behzad. The network helps show where Mahdi Behzad may publish in the future.

Co-authorship network of co-authors of Mahdi Behzad

This figure shows the co-authorship network connecting the top 25 collaborators of Mahdi Behzad. A scholar is included among the top collaborators of Mahdi Behzad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahdi Behzad. Mahdi Behzad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Borzouei, Shiva, et al.. (2022). Impact of interleukin-32α on T helper cell-related cytokines, transcription factors, and proliferation in patients with type 2 diabetes mellitus. Immunopharmacology and Immunotoxicology. 45(3). 268–276. 4 indexed citations
5.
Borzouei, Shiva, et al.. (2021). Changes in T helper cell-related factors in patients with type 2 diabetes mellitus after empagliflozin therapy. Human Immunology. 82(6). 422–428. 19 indexed citations
6.
Sheikh, Vida, et al.. (2020). Evaluation of Interleukin-23 and JAKs/STATs/SOCSs/ROR-γt Expression in Type 2 Diabetes Mellitus Patients Treated With or Without Sitagliptin. Journal of Interferon & Cytokine Research. 40(11). 515–523. 14 indexed citations
7.
Jahangard, Leila & Mahdi Behzad. (2020). Diminished functional properties of T regulatory cells in major depressive disorder: The influence of selective serotonin reuptake inhibitor. Journal of Neuroimmunology. 344. 577250–577250. 11 indexed citations
8.
9.
Sheikh, Vida, et al.. (2020). Enhanced expression of TIGIT but not neuropilin-1 in patients with type 2 diabetes mellitus. Immunology Letters. 225. 1–8. 5 indexed citations
10.
Borzouei, Shiva, Vida Sheikh, Alireza Zamani, et al.. (2019). Anti-Inflammatory Effect of Combined Sitagliptin and Vitamin D3 on Cytokines Profile in Patients with Type 2 Diabetes Mellitus. Journal of Interferon & Cytokine Research. 39(5). 293–301. 17 indexed citations
11.
Sheikh, Vida, Alireza Zamani, Shiva Borzouei, et al.. (2019). Effects of sitagliptin and vitamin D3 on T helper cell transcription factors and cytokine production in clinical subgroups of type 2 diabetes mellitus: highlights upregulation of FOXP3 and IL-37. Immunopharmacology and Immunotoxicology. 41(2). 299–311. 20 indexed citations
12.
Jahangard, Leila, Alireza Zamani, Mohammad Haghighi, et al.. (2019). Interleukin-6 signaling pathway involved in major depressive disorder: selective serotonin reuptake inhibitor regulates IL-6 pathway. Turkish Journal of Biochemistry. 44(6). 831–839. 5 indexed citations
13.
Behzad, Mahdi, et al.. (2019). Effect of 50-Hz Magnetic Fields on Serum IL-1β and IL-23 and Expression of BLIMP-1, XBP-1, and IRF-4. Inflammation. 42(5). 1800–1807. 5 indexed citations
14.
Behzad, Mahdi, Mohammad Mahdi Eftekharian, Iraj Salehi, et al.. (2018). Extremely Low Frequency Electromagnetic Fields Decrease Serum Levels of Interleukin-17, Transforming Growth Factor-β and Downregulate Foxp3 Expression in the Spleen. Journal of Interferon & Cytokine Research. 38(10). 457–462. 17 indexed citations
15.
16.
Sheikh, Vida, et al.. (2018). Decreased regulatory function of CD4+CD25+CD45RA+ T cells and impaired IL‐2 signalling pathway in patients with type 2 diabetes mellitus. Scandinavian Journal of Immunology. 88(4). e12711–e12711. 31 indexed citations
17.
Sheikh, Vida, et al.. (2018). Vitamin D3 inhibits the proliferation of T helper cells, downregulate CD4+ T cell cytokines and upregulate inhibitory markers. Human Immunology. 79(6). 439–445. 49 indexed citations
18.
Saruhan‐Direskeneli, Güher, Travis K. Hughes, Vuslat Yılmaz, et al.. (2016). Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis. Clinical Immunology. 166-167. 81–88. 33 indexed citations
19.
20.
Behzad, Mahdi, Vuslat Yılmaz, Fikret Aysal, et al.. (2013). Association of HLA-DRB1∗14, -DRB1∗16 and -DQB1∗05 with MuSK-myasthenia gravis in patients from Turkey. Human Immunology. 74(12). 1633–1635. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Areez Shafqat Breakdown of academic impact, for papers by Sibel Oğuzkan Balcı Breakdown of academic impact, for papers by Carmela Romano Breakdown of academic impact, for papers by Yongjie Zhao Breakdown of academic impact, for papers by Valērija Groma Breakdown of academic impact, for papers by Citlaltepetl Salinas‐Lara Breakdown of academic impact, for papers by Anne‐Hilde Muris Breakdown of academic impact, for papers by K. Huber
Rankless by CCL
2026